skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All








16 Total results for product and free and sample content found


Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 28 Jul 2022

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

ターゲット市場の実像をつかむ, Biomedtracker: 開発中医薬品をFDA承認確率...

2019 Q3 Outlook Webinar

By Hardik Patel 16 Jun 2022

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. 

Topic immuno-oncology Infectious Diseases

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Gilead Says 16 Cancer Centers Getting Ready To Administer Yescarta

By Joseph Haas 31 Oct 2017

Within weeks of its acquisition of Kite, Gilead is working to launch its first immuno-oncology drug, with a goal of training.

Topic immuno-oncology


PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology

By Dustin Phan 17 Sep 2017

Recently, Informa Pharma Intelligence conduced an insightful webinar regarding the current market landscape and outlook for immuno-oncology.

Topic immuno-oncology

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

BMS' Opdivo Approval In CRC Overshadowed By Keytruda Dominance

02 Aug 2017

The US FDA has approved BMS' Opdivo for previously treated patients with some forms of colorectal cancer, however direct competition from Merck's Keytruda may limit its success.

Topic immuno-oncology Cancer

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

PD-1 Data Emerges In Cervical Cancer

By Lucie Ellis 26 Jul 2017

Leading immunotherapy agents are beginning to report early-stage data from monotherapy and combination trials in advanced cervical cancer – a treatment area with very few approved options.

Topic Cancer immuno-oncology Research & Development Strategy

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Immuno-Oncology Outlook: Getting To The Root Of Head And Neck Cancer

24 Jul 2017

As PD-1 inhibitors march toward earlier-stage head and neck cancers, researchers consider ways to improve the precision of immunotherapy through better patient selection and combinations for this accessible tumor type.

Topic Cancer immuno-oncology

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Boehringer Ingelheim's Partnering Focus: An Interview With Ioannis Sapountzis

By Joseph Haas 04 Jul 2017

Trying to catch up with peers in both immuno-oncology and NASH, the German pharma has assigned Sapountzis to lead its US business development efforts.

Topic Cancer immuno-oncology